October 26, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ciclopirox topical solution (nail lacquer) 8% for treatment of mild to moderate ...
NORTH WALES, Pa. Teva is introducing its generic to the Sanofi-Aventis anti-fungal medication Penlac nail lacquer. The brand lost its patent yesterday and was immediately launched by Sandoz and is now ...
Sept 19 (Reuters) - Perrigo Co said it received final approval from U.S. health regulators for Ciclopirox topical solution, a generic version of Sanofi-Aventis' Penlac nail-fungus treatment. The ...
SAN FRANCISCO (MarketWatch) -- Perrigo Co. after Monday's closing bell said the Food and Drug Administration has granted tentative approval for its ciclopirox topical solution, 8%. The solution is a ...
Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 1989;32:609-19. Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger ...
SAN FRANCISCO (MarketWatch) -- Perrigo Co. said Wednesday it has received final clearance from the Food and Drug Administration to manufacture and market Ciclopirox, a nail lacquer used to treat mild ...
Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...
What is an effective alternative to oral medications or topical ciclopirox (Penlac) for onychomycosis?— Glenn Phillips, PA-C, Lake Forest, Calif. Other topical agents that may be useful in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback